Graham Delano Martin, PA-S Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2563 Branch Dr, Valdese, NC 28690 Phone: 828-432-6177 |
Amy Patel Tillison, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 720 Malcolm Blvd, Valdese, NC 28690 Phone: 828-580-2280 |
News Archive
Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD research community to help advance LRRK2 therapeutic development efforts. The antibodies will be available to Parkinson's researchers in academic/nonprofit and industry labs on a worldwide basis.
The laboratory of Marcos Malumbres, who is head of the Spanish National Cancer Research Centre's (CNIO) Cell Division & Cancer Group, working alongside Isabel Fari-as' team from the University of Valencia, shows, in a study published today in the journal Nature Communications, how in mice the elimination of the Cdh1 protein -a sub-unit of the APC/C complex, involved in the control of cell division-prevents cellular proliferation of rapidly dividing cells.
Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers.
The FluMist Quadrivalent vaccine from AstraZeneca's MedImmune unit protects against two strains of influenza A and two strains of influenza B, and is approved for people ages 2 to 49. Similar to the previously approved FluMist, the new vaccine is a nasal spray that delivers weakened strains of the virus. The vaccine, FluMist Quadrivalent (MedImmune), will be available for the 2013-2014 flu season.
› Verified 6 days ago